Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,370 GBX | +0.31% | +2.66% | +16.70% |
02:25pm | Pfizer and AstraZeneca announce new investments of nearly $1 billion in France | RE |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
ETFs positioned on AstraZeneca PLC
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
9.20% | 11 M€ | +0.83% | - | |
5.39% | 0 M€ | +16.95% | ||
5.17% | 0 M€ | +7.69% | - | |
4.89% | 0 M€ | +12.94% | ||
4.11% | 88 M€ | +10.37% | - | |
3.47% | 0 M€ | +13.20% | ||
2.74% | 4 M€ | -.--% | - | |
2.57% | 6 M€ | -.--% | ||
2.53% | 0 M€ | +7.65% | - | |
2.53% | 0 M€ | +10.93% | ||
1.54% | 29 M€ | +8.37% | - | |
1.51% | 2 M€ | -.--% | - | |
1.51% | 2 M€ | +9.19% | - | |
1.26% | 12 M€ | +15.09% | - | |
1.19% | 0 M€ | +9.46% | ||
1.16% | 10 M€ | -3.35% | - | |
0.97% | 0 M€ | +4.81% | - | |
0.89% | 0 M€ | +7.24% | - | |
0.86% | 276 M€ | +11.40% | - | |
0.70% | 0 M€ | -.--% | - | |
0.69% | 0 M€ | +9.15% | - | |
0.69% | 0 M€ | +11.72% | ||
0.57% | 205 M€ | -.--% | ||
0.54% | 284 M€ | -.--% | ||
0.51% | 23 M€ | -.--% | - | |
0.51% | 786 M€ | -.--% | ||
0.50% | 206 M€ | -.--% | ||
0.48% | 0 M€ | +8.33% | ||
0.43% | 0 M€ | +18.92% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.70% | 240B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B | |
-2.71% | 159B |
- Stock Market
- Equities
- AZN Stock
- Funds and ETFs AstraZeneca PLC